Medicenna Therapeutics Corp Stock Price History
MDNA Stock | CAD 1.66 0.06 3.49% |
Below is the normalized historical share price chart for Medicenna Therapeutics Corp extending back to July 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Medicenna Therapeutics stands at 1.66, as last reported on the 4th of December, with the highest price reaching 1.76 and the lowest price hitting 1.63 during the day.
If you're considering investing in Medicenna Stock, it is important to understand the factors that can impact its price. Medicenna Therapeutics has Sharpe Ratio of -0.0766, which conveys that the firm had a -0.0766% return per unit of risk over the last 3 months. Medicenna Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medicenna Therapeutics' Risk Adjusted Performance of (0.05), mean deviation of 3.88, and Standard Deviation of 5.11 to check out the risk estimate we provide.
At this time, Medicenna Therapeutics' Common Stock is very stable compared to the past year. As of the 4th of December 2024, Common Stock Total Equity is likely to grow to about 68.3 M, while Total Stockholder Equity is likely to drop about 4.9 M. . At this time, Medicenna Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 4th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0, while Price Earnings Ratio is likely to drop (5.20). Medicenna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.9907 | 50 Day MA 2.0284 | Beta 1.189 |
Medicenna |
Sharpe Ratio = -0.0766
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MDNA |
Estimated Market Risk
5.18 actual daily | 46 54% of assets are more volatile |
Expected Return
-0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medicenna Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medicenna Therapeutics by adding Medicenna Therapeutics to a well-diversified portfolio.
Price Book 6.3144 | Book Value 0.075 | Enterprise Value 96.4 M | Enterprise Value Ebitda (6.11) | Shares Float 49.8 M |
Medicenna Therapeutics Stock Price History Chart
There are several ways to analyze Medicenna Stock price data. The simplest method is using a basic Medicenna candlestick price chart, which shows Medicenna Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 1, 2024 | 2.51 |
Lowest Price | November 15, 2024 | 1.45 |
Medicenna Therapeutics December 4, 2024 Stock Price Synopsis
Various analyses of Medicenna Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Medicenna Stock. It can be used to describe the percentage change in the price of Medicenna Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Medicenna Stock.Medicenna Therapeutics Price Daily Balance Of Power | (0.46) | |
Medicenna Therapeutics Price Rate Of Daily Change | 0.97 | |
Medicenna Therapeutics Price Action Indicator | (0.07) | |
Medicenna Therapeutics Accumulation Distribution | 3,684 |
Medicenna Therapeutics December 4, 2024 Stock Price Analysis
Medicenna Stock Price History Data
The price series of Medicenna Therapeutics for the period between Thu, Sep 5, 2024 and Wed, Dec 4, 2024 has a statistical range of 1.06 with a coefficient of variation of 13.77. The daily prices for the period are spread out with arithmetic mean of 2.06. The median price for the last 90 days is 2.1. The company underwent 1:14 stock split on 3rd of March 2017. Medicenna Therapeutics issued dividends to stockholders on 2017-03-03.Open | High | Low | Close | Volume | ||
12/04/2024 | 1.73 | 1.76 | 1.63 | 1.66 | 49,870 | |
12/03/2024 | 1.62 | 1.72 | 1.62 | 1.72 | 34,071 | |
12/02/2024 | 1.70 | 1.73 | 1.59 | 1.62 | 30,722 | |
11/29/2024 | 1.80 | 1.80 | 1.66 | 1.72 | 57,777 | |
11/28/2024 | 1.83 | 1.83 | 1.76 | 1.78 | 6,200 | |
11/27/2024 | 1.78 | 1.88 | 1.76 | 1.78 | 90,983 | |
11/26/2024 | 1.76 | 1.77 | 1.67 | 1.77 | 66,883 | |
11/25/2024 | 1.60 | 1.67 | 1.59 | 1.67 | 50,671 | |
11/22/2024 | 1.53 | 1.57 | 1.49 | 1.57 | 34,606 | |
11/21/2024 | 1.53 | 1.58 | 1.41 | 1.49 | 96,877 | |
11/20/2024 | 1.64 | 1.64 | 1.48 | 1.50 | 38,304 | |
11/19/2024 | 1.61 | 1.65 | 1.60 | 1.62 | 54,797 | |
11/18/2024 | 1.47 | 1.63 | 1.46 | 1.61 | 76,180 | |
11/15/2024 | 1.69 | 1.71 | 1.27 | 1.45 | 201,328 | |
11/14/2024 | 1.70 | 1.91 | 1.69 | 1.70 | 102,196 | |
11/13/2024 | 1.93 | 1.93 | 1.64 | 1.69 | 152,481 | |
11/12/2024 | 2.02 | 2.02 | 1.75 | 1.76 | 433,564 | |
11/11/2024 | 2.59 | 2.59 | 2.03 | 2.07 | 393,529 | |
11/08/2024 | 2.46 | 2.46 | 2.10 | 2.22 | 224,260 | |
11/07/2024 | 2.41 | 2.50 | 2.41 | 2.47 | 70,051 | |
11/06/2024 | 2.43 | 2.43 | 2.29 | 2.41 | 71,630 | |
11/05/2024 | 2.34 | 2.43 | 2.34 | 2.40 | 37,590 | |
11/04/2024 | 2.51 | 2.61 | 2.37 | 2.37 | 80,704 | |
11/01/2024 | 2.37 | 2.62 | 2.34 | 2.51 | 106,391 | |
10/31/2024 | 2.31 | 2.37 | 2.30 | 2.36 | 35,455 | |
10/30/2024 | 2.21 | 2.38 | 2.21 | 2.31 | 90,767 | |
10/29/2024 | 2.32 | 2.32 | 2.21 | 2.22 | 33,736 | |
10/28/2024 | 2.36 | 2.36 | 2.31 | 2.34 | 49,469 | |
10/25/2024 | 2.23 | 2.37 | 2.23 | 2.35 | 82,475 | |
10/24/2024 | 2.10 | 2.25 | 2.10 | 2.22 | 25,263 | |
10/23/2024 | 2.12 | 2.17 | 2.10 | 2.11 | 29,061 | |
10/22/2024 | 2.20 | 2.20 | 2.13 | 2.15 | 19,879 | |
10/21/2024 | 2.22 | 2.27 | 2.20 | 2.22 | 50,803 | |
10/18/2024 | 2.32 | 2.36 | 2.28 | 2.28 | 81,213 | |
10/17/2024 | 2.30 | 2.42 | 2.29 | 2.36 | 67,459 | |
10/16/2024 | 2.36 | 2.37 | 2.28 | 2.29 | 31,551 | |
10/15/2024 | 2.23 | 2.40 | 2.23 | 2.39 | 126,912 | |
10/11/2024 | 2.20 | 2.26 | 2.15 | 2.23 | 78,244 | |
10/10/2024 | 2.21 | 2.24 | 2.09 | 2.21 | 55,150 | |
10/09/2024 | 2.23 | 2.25 | 2.15 | 2.15 | 50,955 | |
10/08/2024 | 2.10 | 2.26 | 2.08 | 2.25 | 120,972 | |
10/07/2024 | 2.21 | 2.21 | 2.05 | 2.09 | 83,348 | |
10/04/2024 | 2.08 | 2.28 | 2.08 | 2.20 | 130,902 | |
10/03/2024 | 2.08 | 2.10 | 2.05 | 2.05 | 39,581 | |
10/02/2024 | 1.95 | 2.15 | 1.95 | 2.10 | 48,737 | |
10/01/2024 | 1.87 | 1.93 | 1.82 | 1.93 | 54,475 | |
09/30/2024 | 1.87 | 1.92 | 1.87 | 1.89 | 11,582 | |
09/27/2024 | 1.89 | 1.92 | 1.87 | 1.87 | 26,650 | |
09/26/2024 | 1.87 | 1.91 | 1.85 | 1.88 | 32,710 | |
09/25/2024 | 1.96 | 1.96 | 1.84 | 1.84 | 134,945 | |
09/24/2024 | 2.00 | 2.00 | 1.94 | 1.96 | 24,395 | |
09/23/2024 | 2.06 | 2.06 | 1.97 | 1.99 | 28,637 | |
09/20/2024 | 2.09 | 2.09 | 2.01 | 2.03 | 24,875 | |
09/19/2024 | 2.05 | 2.09 | 1.96 | 2.08 | 31,123 | |
09/18/2024 | 1.97 | 2.07 | 1.91 | 2.05 | 97,004 | |
09/17/2024 | 2.07 | 2.07 | 1.94 | 2.01 | 158,524 | |
09/16/2024 | 2.09 | 2.12 | 1.98 | 2.03 | 52,976 | |
09/13/2024 | 2.06 | 2.13 | 2.06 | 2.08 | 31,960 | |
09/12/2024 | 2.10 | 2.20 | 2.05 | 2.06 | 68,719 | |
09/11/2024 | 2.21 | 2.25 | 2.17 | 2.19 | 12,377 | |
09/10/2024 | 2.19 | 2.19 | 2.14 | 2.17 | 18,415 |
About Medicenna Therapeutics Stock history
Medicenna Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medicenna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medicenna Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medicenna Therapeutics stock prices may prove useful in developing a viable investing in Medicenna Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 69.6 M | 38.4 M | |
Net Loss | -9 M | -9.5 M |
Medicenna Therapeutics Quarterly Net Working Capital |
|
Medicenna Therapeutics Stock Technical Analysis
Medicenna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
All Next | Launch Module |
Medicenna Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Medicenna Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Medicenna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medicenna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.50) | |||
Total Risk Alpha | (1.11) | |||
Treynor Ratio | (0.51) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Medicenna Stock
Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.